![]()
Thu Sep 12 10:50:56 UTC 2024: ## Dutch Startup XS Innovations Secures €1.1 Million to Revolutionize Hemodialysis Treatment
**Amsterdam, Netherlands -** XS Innovations, a Dutch startup specializing in medical technology, has secured €1.1 million in seed funding to advance its innovative Dynamic AVF (DAVF) device. The funding round was led by a consortium of investors including FIRST fund, Medtech TTT Fund, UNIIQ, Delft Enterprises, Libertatis Ergo Holding, and the Graduate Entrepreneur Fund.
The DAVF is a groundbreaking implantable device designed to alleviate the complications associated with hemodialysis treatment for patients with end-stage kidney disease (ESKD). Unlike traditional methods that maintain a constant high blood flow, the DAVF connects the artery and vein only during dialysis, keeping the AVF closed at other times to ensure normal blood circulation.
This unique technology allows for optimal blood flow control during dialysis (600 ml/min) while restoring normal levels during daily life. By reducing the time of high blood flow by 90%, the DAVF minimizes complications such as turbulent flow, stenosis formation, aneurysm risk, and heart failure.
“The syndicate is confident that the XSI team has the innovation and know-how to further develop the Dynamic AVF device,” said Jaap de Bruin, representing the investor syndicate. “We believe that the Dynamic AVF can have a transformative effect on the outcomes and quality of life in patients receiving dialysis care.”
Toon Stilma, CEO of XS Innovations, expressed pride in the team’s dedication to addressing the root cause of vascular access complications. “We are determined to accelerate the development of the Dynamic AVF and bring this life-changing device to market,” he said.
The new funding will be used to further develop the DAVF and bring it closer to clinical trials. Joris Rotmans, CSO of XS Innovations, believes the device offers a promising solution for ESKD patients who struggle with high re-operation rates and cardiovascular complications. “I am excited about the prospect of creating an alternative that can address these issues,” he stated.
With its innovative approach and strong backing, XS Innovations is poised to make a significant impact on the lives of millions of people worldwide who rely on hemodialysis.